Regulatory News
Friday, May 27, 2016
UPDATE 1-Biogen, AbbVie once-monthly MS injection wins U.S. approval
May 27 (Reuters) - The U.S. Food and Drug Administration on
Friday approved a once-monthly injection for multiple sclerosis
from Biogen Inc and AbbVie Inc, with a boxed
warning.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment